What did @madeleine.lupa actually say?
Almost nothing, medically speaking. The transcript here is "It's always darkest before the moon. Check it out, check it out, check it out." That's it. There are no claims about GLP-1 medications, no dosing advice, no before-and-after explanations, and no stated mechanism for weight loss. The video's content is essentially the caption and hashtags doing the talking.
The hashtags, #weightloss, #weightlossjouney, and #weightlosstransformation, combined with the GLP-1 category tag, suggest this is a transformation-style post likely showing physical results attributed to GLP-1 therapy. But attribution is the viewer's inference, not the creator's explicit statement. That ambiguity matters more than it might seem when millions of people are watching.
Does the science back this up?
There's nothing specific to back up or dispute here because no medical claim was made. What we can say is that the implied narrative, GLP-1 treatment producing visible weight loss transformation, is broadly supported by the evidence.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide producing average body weight reductions of up to 22.5% over 72 weeks in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg producing roughly 14.9% mean weight reduction over 68 weeks. These are real, peer-reviewed results from large randomized controlled trials. If this creator's transformation reflects GLP-1 use, that outcome is plausible and scientifically grounded.
What the science does not support is the idea that results are universal, effortless, or permanent once medication stops. The STEP 4 trial (Rubino et al., 2021, JAMA) found that participants who discontinued semaglutide regained most of their lost weight within a year.
What did they get wrong (or right)?
Credit where it's due: by saying almost nothing, @madeleine.lupa avoided making any of the dangerous claims that flood GLP-1 content on TikTok. No dosing recommendations, no "this cured my insulin resistance" declarations, no claims that compounded semaglutide is identical to Wegovy. That restraint, intentional or not, is genuinely better than most content in this category.
The concern is subtler. Transformation videos without context create a specific kind of misleading impression. They imply that the result shown is typical, that the path was straightforward, and that the viewer can reasonably expect the same outcome. Research on health content on social media, including Pilipiec et al. (2023, International Journal of Environmental Research and Public Health), has documented how aspirational weight loss content can distort expectations and drive unsupervised medication use. The video isn't lying. It just isn't telling you anything that would help you make a safer, more realistic decision.
What should you actually know?
GLP-1 receptor agonists are legitimate, FDA-approved medications with strong clinical trial data behind them. They are not magic, and they are not without risk. Common side effects include nausea, vomiting, and gastrointestinal distress. Rarer but more serious concerns include pancreatitis and, in rodent studies, thyroid C-cell tumors, which is why these drugs carry a black box warning for patients with a personal or family history of medullary thyroid carcinoma.
A transformation video on TikTok is not a prescription, a consultation, or a risk assessment. If you're considering a GLP-1 medication, that conversation needs to happen with a licensed clinician who can review your full medical history. The results shown in content like this are real for some people. They are not guaranteed for anyone.
- Weight regain after stopping GLP-1 therapy is well-documented (Rubino et al., 2021, JAMA).
- Response varies significantly by individual, comorbidities, and adherence.
- Compounded versions of semaglutide or tirzepatide are not equivalent to brand-name Wegovy or Zepbound. Do not assume interchangeability.